Hemab Therapeutics Holdings, Inc.

COAG chart

Hemab Therapeutics Holdings, Inc. news

• Hemab Therapeutics (NASDAQ:COAG) Stock Falls 6.5% - Here's What Happened

  MarketBeat · Nov 9, 1:33 PM EST

• COAG Initiates Coverage On by LifeSci Capital -- Rating Set to Outperform

  GuruFocus · Nov 9, 9:36 AM EST

• Hemab Therapeutics (NASDAQ:COAG) Stock Rated "Outperform" in New Coverage at Lifesci Capital

  MarketBeat · Nov 9, 8:39 AM EST

• LifeSci Capital initiates coverage of Hemab Therapeutics Hldgs at Outperform, sets price target at $65

  TradingView · Nov 9, 8:15 AM EST

• Hemab Therapeutics Initiates SOLARA, a Pivotal Phase 3 Trial of Sutacimig in Glanzmann Thrombasthenia

  Yahoo Finance · Nov 9, 7:00 AM EST

• Wedbush Maintains Hemab Therapeutics Holdings(COAG.US) With Buy Rating, Maintains Target Price $64

  Moomoo · Nov 6, 9:49 AM EST

• An investor reports sole voting power over 4.87M Hemab Therapeutics (COAG) shares.

  Stock Titan · Nov 6, 9:45 AM EST

• Is Hemab Therapeutics (NASDAQ:COAG) Up 43.77% in a Month With No Clear Catalyst?

  kalkine.ca · Nov 5, 12:42 PM EST

• Hemab Therapeutics Holdings, Inc. (COAG) stock price, news, quote and history

  Yahoo Finance UK · Nov 5, 4:37 AM EST

• Hemab Therapeutics to Present Clinical and Preclinical Data from Multiple Blood Coagulation Programs at the 68th ASH Annual Meeting and Exposition

  Yahoo Finance · Nov 4, 9:05 AM EST

• Hemab Therapeutics to Report Third Quarter 2026 Financial Results and Provide a Corporate Update on November 10, 2026

  Yahoo Finance · Nov 3, 7:00 AM EST

• Hemab Therapeutics Holdings (COAG) Joins Russell Indices, Is The Stock Still Trading At A Discount?

  Yahoo Finance · Sep 28, 9:07 PM EDT

Hemab Therapeutics Holdings, Inc. key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 8-K8-K2026-09-24
• 10-Q10-Q2026-08-11
• 8-K8-K2026-08-11
• 10-Q10-Q2026-05-21
• 8-K8-K2026-05-21
• 8-K8-K2026-05-11
• 8-K8-K2026-05-04
• S-1S-12026-04-10

About Hemab Therapeutics Holdings, Inc.

Ticker

COAG (Nasdaq)

Industry

Biological Products, (No Diagnostic Substances)

Headquarters

Cambridge, MA

Incorporated in

DE

Fiscal year end

December 31

SEC CIK

2114044

Frequently asked questions